...
首页> 外文期刊>Acta veterinaria scandinavica >Evaluation of an in-clinic Serum Amyloid A (SAA) assay and assessment of the effects of storage on SAA samples
【24h】

Evaluation of an in-clinic Serum Amyloid A (SAA) assay and assessment of the effects of storage on SAA samples

机译:评估诊所中的血清淀粉样蛋白A(SAA)分析和评估储存对SAA样品的影响

获取原文
           

摘要

Background An in-clinic assay for equine serum amyloid A (SAA) analysis, Equinostic EVA1, was evaluated for use in a clinical setting. Stability of SAA in serum samples was determined. Methods Intra- and inter- assay variation of the in-clinic method was determined. The in-clinic method (EVA1) results were compared to a reference method (Eiken LZ SAA) with 62 patient samples. For samples with SAA concentrations within the assay range of EVA1 (10-270 mg/L), differences between the methods were evaluated in a difference plot. Linearity under dilution was evaluated in two samples. Stability of SAA in three serum pools stored at 4°C and approximately 22°C was evaluated with the reference method day 0, 1, 2, 4, 7, 17 and analysed with a two-way ANOVA. Results The imprecision (coefficient of variation, CV) for the in-clinic method was acceptable at higher SAA concentrations with CV values of 7,3-12%, but poor at low SAA concentrations with CV values of 27% and 37% for intra- and inter-assay variation respectively. Recovery after dilution was 50-138%. The in-clinic assay and the reference method identified equally well horses with low (270 mg/L) SAA concentrations. Within the assay range of the in-clinic method, 10-270 mg/L, the difference between the two methods was slightly higher than could be explained by the inherent imprecision of the assays. There were no significant changes of serum SAA concentrations during storage. Conclusions The in-clinic assay identified horses with SAA concentrations of 270 mg/L in a similar way as the reference method, and provided an estimate of the SAA concentration in the range of 10-270 mg/L. The imprecision of the in-clinic method was acceptable at high SAA concentrations but not at low concentrations. Dilution of samples gave inconsistent results. SAA was stable both at room temperature and refrigerated, and thus samples may be stored before analysis with the reference method.
机译:背景技术评估了用于马血清淀粉样蛋白A(SAA)分析的临床试验,即Equinostic EVA1,用于临床环境。确定了血清样品中SAA的稳定性。方法确定临床方法内和试验间的差异。将临床方法(EVA1)的结果与参考方法(Eiken LZ SAA)的62个患者样本进行了比较。对于SAA浓度在EVA1(10-270 mg / L)测定范围内的样品,在差异图中评估了方法之间的差异。在两个样品中评估了稀释下的线性。在第0、1、2、4、7、17天的参考方法中评估了分别储存在4°C和约22°C的三个血清库中SAA的稳定性,并通过双向方差分析进行了分析。结果在较高SAA浓度下,CV值为7,3-12%时,临床方法的不精确度(变异系数,CV)是可以接受的,而在较低SAA浓度下,内部方法的不精确度(变异系数,CV)为27%和37% -和批间差异。稀释后的回收率为50-138%。临床试验和参考方法确定的SAA浓度低(270 mg / L)的马同样好。在临床方法的测定范围内(10-270 mg / L),两种方法之间的差异略高于测定固有的不精确性。储存期间血清SAA浓度无明显变化。结论在临床试验中,SAA浓度为270 mg / L的马与参考方法相似,鉴定出的SAA浓度在10-270 mg / L的范围内。在高SAA浓度下,临床方法的不精确性是可以接受的,但在低浓度下是不可接受的。样品稀释得到不一致的结果。 SAA在室温和冷藏下均稳定,因此样品可以在使用参考方法进行分析之前进行存储。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号